This is 100% correct. The problem here does not lie with the Company nor the Management in my opinion. The regulatory advice that the Company has received has been very poor IMO. The constant delays, slow process and ever changing EU regulations has hindered the CE Mark process significantly.
These delays then create anxiety with retail investors as they remember what happened last March.
Again, here we are in 2020 with no outcome and still waiting. I have no doubt that the Company is equally frustrated as are shareholders, doctors, surgeons and even patients.
Let’s see what eventuates over the next couple of weeks. We should get an update by the Company with its Half Year Report that should come out soon. Going by last year, the Half Year Report was released in late February.
Cheers
GW
OSL Price at posting:
18.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)